Careers

Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and inborn errors of metabolism.
NASDAQ: AGIO$40.30 Stock is Up 0.21 (0.52%)

UPCOMING EVENTS

Read more
Thursday, August 7, 2014 8:30 a.m. ET
Q2 2014 Agios Pharmaceuticals Inc Earnings Conference Call

CONTACTS

Investor Inquiries:
General inquiries: investors@agios.com

Institutional Investors and Financial Analysts:
Lora Pike
617-649-8608
Lora.pike@agios.com

Media Inquiries:
Dan Budwick
Pure Communications
973-271-6085